Related Experiment Video
Updated: Jul 19, 2026
08:32
Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
How to modulate inflammatory cytokines in liver diseases
Herbert Tilg1, Arthur Kaser, Alexander R Moschen
1Department of Medicine, Division of Gastroenterology and Hepatology, Innsbruck Medical University, Austria. Herbert.Tilg@uibk.ac.at
Summary
Cytokine therapies targeting tumor necrosis factor-alpha (TNF-alpha) show mixed results for liver diseases. While potentially beneficial for alcoholic hepatitis and hepatitis C, TNF-alpha neutralization may worsen hepatitis B.
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Liver diseases often involve inflammatory processes driven by pro- and anti-inflammatory cytokines.
- Cytokine dysregulation contributes to liver fibrosis and cirrhosis.
- Tumor necrosis factor-alpha (TNF-alpha) plays a key role in severe alcoholic hepatitis.
Purpose of the Study:
- To review the role of cytokine modulation in liver disease treatment.
- To evaluate the efficacy and safety of anti-TNF therapies in various chronic liver conditions.
- To explore the potential of other anti-inflammatory cytokines like IL-10 and adiponectin.
Main Methods:
- Review of existing clinical trials and case reports on cytokine-targeted therapies.
- Analysis of the impact of TNF-alpha neutralization in alcoholic hepatitis, hepatitis C, and hepatitis B.
- Examination of studies involving interleukin-10 (IL-10) and adiponectin in liver injury models and patient cohorts.
Main Results:
- Anti-TNF agents like infliximab and etanercept have shown promise but also potential detrimental effects in alcoholic hepatitis.
- Etanercept demonstrated benefits in chronic hepatitis C, with TNF-alpha neutralization appearing safe in some cases.
- TNF-alpha neutralization may exacerbate chronic hepatitis B, potentially leading to fatalities.
- Interleukin-10 (IL-10) shows anti-inflammatory effects in hepatitis C but may act as a proviral agent.
- Adiponectin exhibits anti-inflammatory potential in experimental liver injury models.
Conclusions:
- Cytokine pathway interference offers a promising therapeutic avenue for liver diseases.
- Targeting TNF-alpha requires careful consideration due to differential effects across liver conditions.
- Further research into IL-10 and adiponectin may yield novel anti-inflammatory treatments for liver disorders.
Related Concept Videos
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...